Publication Date:
2015-03-07
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Haussecker, Dirk -- Kay, Mark A -- R01 AI071068/AI/NIAID NIH HHS/ -- New York, N.Y. -- Science. 2015 Mar 6;347(6226):1069-70. doi: 10.1126/science.1252967.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉RNAi Therapeutics Consulting, Rastatt, Germany. dirk.haussecker@gmail.com markay@stanford.edu. ; Pediatrics and Genetics, Stanford University, Stanford, CA, USA. dirk.haussecker@gmail.com markay@stanford.edu.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/25745148" target="_blank"〉PubMed〈/a〉
Keywords:
Amyloid Neuropathies, Familial/genetics/therapy
;
Cardiovascular Diseases/therapy
;
*Drug Delivery Systems
;
*Drug Discovery
;
Gene Targeting/*methods
;
Hepatitis B/*therapy
;
Humans
;
Liver/metabolism
;
Liver Neoplasms/therapy
;
Nanoparticles/*administration & dosage/chemistry
;
Prealbumin/genetics
;
*RNA Interference
;
RNA, Double-Stranded/genetics
;
RNA, Messenger/antagonists & inhibitors
;
RNA, Small Interfering/*genetics
;
Templates, Genetic
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
